About the Journal
Volume 7, 2026
Online Edition: ISSN 2712-0082Â Â
Co-Editor-in-Chief:Â Pintong Huang
Professor
Zhejiang University, Hangzhou, China
Co-Editor-in-Chief:Â Chaozong Liu
Professor
University College London, London, United Kingdom
Executive Editor: Zhiwen Luo
Principal Investigator
Fudan Zhangjiang Institute, Fudan University, Shanghai, China
Â
BIOI launched in 2020; previously published in 4 issues per volume, the journal has adopted a continuous article publication process from 2024. Volume 7 will publish in 2026.
🧬 Can preventive and personalised medicine reshape how we age? 🌍
Join Dr Kevin White, Founder and Physician at Prime Health Associates, as he explores in this webinar how longevity science can be applied in real-world clinical practice to support healthier, longer lives.
Liquid biopsies offer a minimally invasive way to monitor minimal residual disease and track tumor evolution. This technology is vital for precision oncology and improving long-term patient survival.
Self-Renewing Blood Progenitors Could Expand the Reach of Cancer Cell Therapy
An engineerable platform for self-renewing immune progenitor cells could enable scalable #cancerimmunotherapies that target tumors more effectively
@USC
#celltherapy #immunecell
BIO Integration is indexed in EBSCO, EMBASE, Scopus, CAS, DOAJ, Research4Life, Ulrich’s web, OCLC, WorldCat, Primo Central (Ex Libris), Sherpa Romeo, CNKI Scholar (Chinese National Knowledge Infrastructure) and Summon Databases.
